BILL NUMBER: SB 142	CHAPTERED  09/22/04

	CHAPTER  687
	FILED WITH SECRETARY OF STATE  SEPTEMBER 22, 2004
	APPROVED BY GOVERNOR  SEPTEMBER 22, 2004
	PASSED THE SENATE  AUGUST 26, 2004
	PASSED THE ASSEMBLY  AUGUST 23, 2004
	AMENDED IN ASSEMBLY  AUGUST 18, 2004
	AMENDED IN ASSEMBLY  AUGUST 5, 2004
	AMENDED IN ASSEMBLY  JUNE 21, 2004
	AMENDED IN ASSEMBLY  JUNE 8, 2004
	AMENDED IN ASSEMBLY  MAY 3, 2004
	AMENDED IN SENATE  JANUARY 6, 2004
	AMENDED IN SENATE  MARCH 24, 2003

INTRODUCED BY   Senator Alpert
   (Principal coauthor:  Assembly Member Cohn)
   (Coauthors:  Senators Kuehl, McPherson, and Speier)
   (Coauthors:  Assembly Members Lieber, Maddox, Maldonado, Plescia,
Richman, and Spitzer)

                        FEBRUARY 6, 2003

   An act to amend Section 125001 of the Health and Safety Code,
relating to genetic testing.


	LEGISLATIVE COUNSEL'S DIGEST


   SB 142, Alpert.  Genetic testing.
   Existing law requires the State Department of Health Services to
establish a program for the development and evaluation of genetic
disease testing to provide genetic screening and followup services
for persons who elect to have the screening.  Existing law requires
the department to report to the Legislature regarding the progress of
the program on or before January 1, 2002.
   Existing law requires the department to expand statewide screening
of newborns to include tandem mass spectrometry screening for fatty
acid oxidation, amino acid, organic acid disorders, and congenital
adrenal hyperplasia, and to provide information with respect to these
disorders and testing resources to all women receiving prenatal care
and admitted to a hospital for delivery.  If the department is
unable to provide statewide screening for these disorders by July 1,
2005, existing law requires the department to temporarily obtain
statewide screening for these disorders from one or more
laboratories, through a competitive bid process.
   This bill would extend the date by which the department would be
required to obtain screening from laboratories by competitive bid to
August 1, 2005.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:


  SECTION 1.  Section 125001 of the Health and Safety Code is amended
to read:
   125001.  (a) The department shall establish a program for the
development, provision, and evaluation of genetic disease testing,
and may provide laboratory testing facilities or make grants to,
contract with, or make payments to, any laboratory that it deems
qualified and cost-effective to conduct testing or with any metabolic
specialty clinic to provide necessary treatment with qualified
specialists.  The program shall provide genetic screening and
followup services for persons who have the screening.
   (b) The department shall expand statewide screening of newborns to
include tandem mass spectrometry screening for fatty acid oxidation,
amino acid, and organic acid disorders and congenital adrenal
hyperplasia as soon as possible.  The department shall provide
information with respect to these disorders and testing resources
available, to all women receiving prenatal care and to all women
admitted to a hospital for delivery.  If the department is unable to
provide this statewide screening by August 1, 2005, the department
shall temporarily obtain these testing services through a competitive
bid process from one or more public or private laboratories that
meet the department's requirements for testing, quality assurance,
and reporting.  If the department determines that contracting for
these services is more cost-effective, and meets the other
requirements of this chapter, than purchasing the tandem mass
spectrometry equipment themselves, the department shall contract with
one or more public or private laboratories.
   (c) The department shall report to the Legislature regarding the
progress of the program on or before July 1, 2006.  The report shall
include the costs for screening, followup, and treatment as compared
to costs and morbidity averted for each condition tested for in the
program.